$ATAO
ALTAIR INTERNATIONAL CORP.

2023 Q4 Form 10-Q Financial Statement

#000155479523000343 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $34.93K $50.00K
YoY Change -75.26% -69.81%
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $34.93K $52.46K
YoY Change -75.26% -68.33%
Operating Profit -$34.93K -$52.46K
YoY Change -75.26% -68.33%
Interest Expense $36.25K $39.15K
YoY Change 57.7% -45.96%
% of Operating Profit
Other Income/Expense, Net $121.1K $12.38K
YoY Change -2727.1% -107.94%
Pretax Income $86.16K -$40.07K
YoY Change -159.1% -87.54%
Income Tax
% Of Pretax Income
Net Earnings $86.16K -$40.07K
YoY Change -159.1% -87.54%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 24.69M shares 24.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.59K $10.00K
YoY Change -50.67% -37.26%
Cash & Equivalents $12.59K $8.030K
Short-Term Investments
Other Short-Term Assets $3.990K $10.00K
YoY Change -88.89%
Inventory
Prepaid Expenses $3.990K $7.980K
Receivables
Other Receivables
Total Short-Term Assets $16.58K $16.01K
YoY Change -35.01% -84.89%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $16.58K $16.01K
Total Long-Term Assets $0.00 $0.00
Total Assets $16.58K $16.01K
YoY Change -35.01% -84.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.500K
YoY Change -90.91%
Accrued Expenses $76.63K $60.00K
YoY Change 10482.01%
Deferred Revenue
YoY Change
Short-Term Debt $194.7K $160.0K
YoY Change 309.16% 57.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $278.8K $373.2K
YoY Change 25.78% 80.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $278.8K $373.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $278.8K $373.2K
YoY Change 25.78% 80.36%
SHAREHOLDERS EQUITY
Retained Earnings -$17.24M -$17.33M
YoY Change 7.55% 9.08%
Common Stock $25.02K $24.69K
YoY Change -95.92% -95.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$262.2K -$357.2K
YoY Change
Total Liabilities & Shareholders Equity $16.58K $16.01K
YoY Change -35.01% -84.89%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $86.16K -$40.07K
YoY Change -159.1% -87.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.800K -$50.00K
YoY Change -85.05% -21.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.500K 30.00K
YoY Change -78.57% -40.0%
NET CHANGE
Cash From Operating Activities -3.800K -50.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 7.500K 30.00K
Net Change In Cash 3.700K -20.00K
YoY Change -61.38% 44.2%
FREE CASH FLOW
Cash From Operating Activities -$3.800K -$50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
usd
us-gaap Exploration Expense
ExplorationExpense
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001570937
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Exploration Expense
ExplorationExpense
usd
us-gaap Exploration Expense
ExplorationExpense
usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2023Q3 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
usd
ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
usd
CY2023Q3 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2022Q3 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17327559 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
ALTAIR INTERNATIONAL CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
333-190235
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385465
dei Entity Address Address Line1
EntityAddressAddressLine1
322 North Shore Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1B, Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15212
dei City Area Code
CityAreaCode
412
dei Local Phone Number
LocalPhoneNumber
770-3140
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24692449 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8030 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28897 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7980 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7980 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
16010 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
36877 usd
CY2023Q3 us-gaap Assets
Assets
16010 usd
CY2023Q1 us-gaap Assets
Assets
36877 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3500 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
46500 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25500 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
10912 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3889 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
144353 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
47844 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
157304 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
373234 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
183067 usd
CY2023Q3 us-gaap Liabilities
Liabilities
373234 usd
CY2023Q1 us-gaap Liabilities
Liabilities
183067 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692449 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692449 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692449 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692449 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17327559 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17116525 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-357224 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16010 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36877 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12000 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
102000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
24000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
204000 usd
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7500 usd
CY2022Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7500 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
15000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
15000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32957 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56132 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54366 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88240 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
52457 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
165632 usd
us-gaap Operating Expenses
OperatingExpenses
93366 usd
us-gaap Operating Expenses
OperatingExpenses
307240 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-52457 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-165632 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-93366 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-307240 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
39149 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
72448 usd
us-gaap Interest Expense
InterestExpense
73533 usd
us-gaap Interest Expense
InterestExpense
136303 usd
CY2022Q3 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
29823 usd
ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
29823 usd
CY2023Q3 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
51532 usd
CY2022Q3 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-113359 usd
ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-33263 usd
ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-99044 usd
ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
10872 usd
ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
6149 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12383 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-155984 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-117668 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-211673 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-40074 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-321616 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-211034 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-518913 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-40074 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-321616 usd
us-gaap Net Income Loss
NetIncomeLoss
-211034 usd
us-gaap Net Income Loss
NetIncomeLoss
-518913 usd
CY2023Q3 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.00
CY2022Q3 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.01
ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.01
ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.02
CY2023Q3 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24692449 shares
CY2022Q3 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24191427 shares
ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24692449 shares
ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24000359 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-317150 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-40074 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-357224 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15451 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
63861 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-197297 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-117985 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
338602 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-321616 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-100999 usd
us-gaap Net Income Loss
NetIncomeLoss
-211034 usd
us-gaap Net Income Loss
NetIncomeLoss
-518913 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66509 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
129628 usd
us-gaap Share Based Compensation
ShareBasedCompensation
180000 usd
ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
29823 usd
ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
10872 usd
ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
6149 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-33263 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-99044 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3500 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-19500 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
21000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12500 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5264 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-7023 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-6675 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75867 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89976 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
55000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
35000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20867 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4976 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20917 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8030 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15941 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
205244 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zXoSoWm54dX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zJCzp02M3FH2">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zTRSuDKriK26" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_866_zuj3hyFig1Li">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2022Q3 us-gaap Share Price
SharePrice
0.051
ATAO Conversion Price Minimum
ConversionPriceMinimum
0.287
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
35872 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
33263 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
157304 usd
CY2023Q3 us-gaap Share Price
SharePrice
0.0415
ATAO Conversion Price Maximum
ConversionPriceMaximum
0.032
CY2023 ATAO Conversion Price Minimum
ConversionPriceMinimum
0.015
CY2023 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.056
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.2453 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
3.0198 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.8753 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.0008 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0555 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0561 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0464 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0494 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y3M
ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y8M15D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M17D
CY2023 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M26D
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 25
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
500000000 shares
ATAO Common Stock Reclassed To Additional Paid In Capital
CommonStockReclassedToAdditionalPaidInCapital
592619 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
ATAO Aggregate Fair Value Of Warrants
AggregateFairValueOfWarrants
180000 usd
CY2023Q3 ATAO Warrants Estimates Used Stock Price
WarrantsEstimatesUsedStockPrice
4.50
ATAO Warrants Estimates Used Exercise Price
WarrantsEstimatesUsedExercisePrice
0.25
ATAO Warrants Estimates Used Risk Free Rate
WarrantsEstimatesUsedRiskFreeRate
0.0157 pure
ATAO Warrants Estimates Used Volatility
WarrantsEstimatesUsedVolatility
7.3546 pure
us-gaap Officers Compensation
OfficersCompensation
18000 usd
us-gaap Officers Compensation
OfficersCompensation
24000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
24000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
18000 usd
ATAO Stock Issued During Period Shares Related Parties2
StockIssuedDuringPeriodSharesRelatedParties2
400000 shares
ATAO Stock Issued During Period Price Per Share Related Parties2
StockIssuedDuringPeriodPricePerShareRelatedParties2
0.90
ATAO Stock Issued Related Party Non Cash Stock Compensation Expense2
StockIssuedRelatedPartyNonCashStockCompensationExpense2
360000 usd

Files In Submission

Name View Source Status
0001554795-23-000343-index-headers.html Edgar Link pending
0001554795-23-000343-index.html Edgar Link pending
0001554795-23-000343.txt Edgar Link pending
0001554795-23-000343-xbrl.zip Edgar Link pending
atao-20230930.xsd Edgar Link pending
atao1114form10q.htm Edgar Link pending
atao1114form10qexh31_1.htm Edgar Link pending
atao1114form10qexh32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
atao-20230930_cal.xml Edgar Link unprocessable
atao-20230930_lab.xml Edgar Link unprocessable
atao-20230930_pre.xml Edgar Link unprocessable
atao-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atao1114form10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending